# PRIMARY CARE OPIOID USE DISORDERS TREATMENT TRIAL (CTN-0074). 9/1/2020 - 12/31/2021. N01DA-19-2250. TASK ORDER 75N95020F00004 (TO15).

> **NIH NIH N01** · THE EMMES COMPANY, LLC · 2020 · $236,371

## Abstract

PRIMARY CARE OPIOID USE DISORDERS TREATMENT TRIAL (CTN-0074).

## Key facts

- **NIH application ID:** 10288032
- **Project number:** 75N95019D00013-0-759502000004-1
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** PAUL VANVELDHUISEN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $236,371
- **Award type:** —
- **Project period:** 2020-09-01 → 2021-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10288032

## Citation

> US National Institutes of Health, RePORTER application 10288032, PRIMARY CARE OPIOID USE DISORDERS TREATMENT TRIAL (CTN-0074). 9/1/2020 - 12/31/2021. N01DA-19-2250. TASK ORDER 75N95020F00004 (TO15). (75N95019D00013-0-759502000004-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10288032. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*